Reflections on so-called culture-negative osteoarticular infections in pediatric populations - Report - MDSpire

Reflections on so-called culture-negative osteoarticular infections in pediatric populations

  • By

  • Ahmer Ahmad Khan

  • Giacomo De Marco

  • Elio Paris

  • Oscar Vazquez

  • Christina Steiger-Tuk

  • Romain Dayer

  • Dimitri Ceroni

  • May 11, 2026

  • 0 min

Share

Clinical Report: Insights into Culture-Negative Osteoarticular Infections in Pediatric Patients

Overview

Revise to include specific culture negativity rates for acute hematogenous osteomyelitis and septic arthritis.

Background

Osteoarticular infections in pediatric patients can lead to serious long-term consequences, including impaired bone growth and joint function. Accurate identification of causative pathogens is essential for effective treatment and improved outcomes. However, a significant number of OAIs remain culture-negative, complicating the understanding of their epidemiology and management.

Data Highlights

No numerical data available in the source material.

Key Findings

  • Culture-negative cases account for 24%–68% of acute hematogenous osteomyelitis and 21%–70% of septic arthritis in children.
  • Modern diagnostic methods, particularly PCR, have increased pathogen identification rates by two- to threefold compared to traditional culture methods.
  • Kingella kingae is now recognized as the leading cause of OAIs in children under 4 years of age.
  • More than 20% of OAIs remain without identified pathogens, suggesting the presence of unrecognized fastidious organisms.
  • Subacute hematogenous osteomyelitis (SAHO) presents unique diagnostic challenges, with PCR positivity exceeding 60% compared to less than 25% for culture.

Clinical Implications

Healthcare professionals should consider the limitations of traditional culture methods in diagnosing pediatric OAIs and utilize molecular diagnostics to enhance pathogen detection. Awareness of fastidious organisms, such as Kingella kingae, is crucial for timely and appropriate treatment.

Conclusion

The persistence of culture-negative OAIs in pediatric patients underscores the need for continued advancements in diagnostic technologies to improve pathogen identification and patient outcomes.

Related Resources & Content

  1. PIDS/IDSA, Guidelines, 2023 -- PIDS/IDSA 2023 Guidelines for Diagnosing and Managing Acute Bacterial Arthritis in Pediatrics
  2. Burns JD, Infection, 2022 -- Effect of Pediatric Infectious Disease Consultation on Prompt Transition to Oral Antibiotics for Bone and Joint Infections
  3. Frontiers in Pediatrics, 2026 -- Progressive Limb Necrosis as a Portal to Multifocal Osteomyelitis in Pediatric Septic Shock: A Tissue-Oriented Management Paradigm
  4. phoenix children's medical connection — Metagenomic Next-Generation Sequencing in Osteoarticular Infections With a Focus on Pediatrics: Current Concepts and Clinical Applications
  5. Infection — Preoperative Culturing of Synovial Fluid Shows Limited Effectiveness in Identifying Pathogens in Periprosthetic Joint Infections
  6. Metagenomic Next-Generation Sequencing in Osteoarticular Infections With a Focus on Pediatrics: Current Concepts and Clinical Applications
  7. PIDS/IDSA 2023 Guidelines for Diagnosing and Managing Acute Bacterial Arthritis in Pediatrics
  8. Frontiers | Bacteriological diagnosis of osteoarticular infections caused by Kingella kingae; a narrative review
  9. Clinical Utility of a Multiplex PCR Panel (BioFire Joint Infection®) in the Adjustment of Empiric Antimicrobial Therapy: Experience in Pediatric Osteoarticular Infections | MDPI
  10. 16S Ribosomal RNA Gene PCR and Sequencing for Pediatric Infection Diagnosis, United States, 2020–2023 - Volume 31, Supplement—May 2025 - Emerging Infectious Diseases journal - CDC
  11. Next Generation Sequencing for Diagnosing Primary Osteoarticular Infections Compared to Conventional Culture: A Systematic Review and Meta-Analysis - ScienceDirect
  12. Oral versus intravenous empirical antibiotics in children and adolescents with uncomplicated bone and joint infections: a nationwide, randomised, controlled, non-inferiority trial in Denmark - ScienceDirect

Original Source(s)

Related Content